Literature DB >> 21167526

Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.

Rodolphe Thuret1, Maxine Sun, Firas Abdollah, Lars Budaus, Giovanni Lughezzani, Daniel Liberman, Monica Morgan, Rupinder Johal, Claudio Jeldres, Mathieu Latour, Shahrokh F Shariat, François Iborra, Jacques Guiter, Jean-Jacques Patard, Paul Perrotte, Pierre I Karakiewicz.   

Abstract

PURPOSE: Penile cancer is rare. Thus, predicting cancer specific mortality may be difficult. We devised an accurate and yet easily applicable predictive rule that compares favorably with 2 previous models (73.8% and 74.7% accuracy, respectively).
MATERIALS AND METHODS: We identified patients treated with primary tumor excision for all stages of penile squamous cell carcinoma between 1998 and 2006. Disease stage definitions using Surveillance, Epidemiology and End Results stage, American Joint Committee on Cancer stage and TNM classification, and tumor grade were used to predict cancer specific mortality. Predictive accuracy estimates were compared using the DeLong method for related AUCs.
RESULTS: Surveillance, Epidemiology and End Results stage alone (1 predictor variable) was least accurate (74.5%). American Joint Committee on Cancer stage with tumor grade (2 predictor variables) was the most simple and most accurate (80.9%, p <0.001). A benefit similar to that of American Joint Committee on Cancer stage with tumor grade was seen for TNM classification and TG (80.7%, p = 0.8). However, this rule (4 predictor variables) was more complex than American Joint Committee on Cancer stage and tumor grade.
CONCLUSIONS: American Joint Committee on Cancer stage combined with tumor grade is the simplest, most accurate cancer specific mortality prediction rule after primary tumor excision for penile squamous cell carcinoma. This method is also more accurate than 2 previous cancer specific mortality prediction rules. Copyright Â
© 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21167526     DOI: 10.1016/j.juro.2010.09.111

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression.

Authors:  Mark W Ball; Stephania M Bezerra; Alcides Chaux; Sheila F Faraj; Nilda Gonzalez-Roibon; Enrico Munari; Rajni Sharma; Trinity J Bivalacqua; George J Netto; Arthur L Burnett
Journal:  Urology       Date:  2016-02-18       Impact factor: 2.649

2.  Comparing ROC curves derived from regression models.

Authors:  Venkatraman E Seshan; Mithat Gönen; Colin B Begg
Journal:  Stat Med       Date:  2012-10-03       Impact factor: 2.373

Review 3.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

4.  Contemporary management of penile cancer: greater than 15 year MSKCC experience.

Authors:  Kelvin A Moses; Andrew Winer; John P Sfakianos; Stephen A Poon; Matthew Kent; Melanie Bernstein; Paul Russo; Guido Dalbagni
Journal:  Can J Urol       Date:  2014-04       Impact factor: 1.344

5.  The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.

Authors:  Julie Steinestel; Andreas Al Ghazal; Annette Arndt; Thomas J Schnoeller; Andres J Schrader; Peter Moeller; Konrad Steinestel
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

6.  A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer.

Authors:  Zai-Shang Li; Antonio Augusto Ornellas; Christian Schwentner; Xiang Li; Alcides Chaux; Georges Netto; Arthur L Burnett; Yong Tang; JiunHung Geng; Kai Yao; Xiao-Feng Chen; Bin Wang; Hong Liao; Nan Liu; Peng Chen; Yong-Hong Lei; Qi-Wu Mi; Hui-Lan Rao; Ying-Ming Xiao; Qi-Lin Wang; Zi-Ke Qin; Zhuo-Wei Liu; Yong-Hong Li; Zi-Jun Zou; Jun-Hang Luo; Hui Li; Hui Han; Fang-Jian Zhou
Journal:  Cancer Commun (Lond)       Date:  2018-11-23

7.  External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery.

Authors:  Yao Zhu; Wei-Jie Gu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen
Journal:  Chin J Cancer       Date:  2014-02-19

8.  Nomogram prediction of overall survival based on log odds of positive lymph nodes for patients with penile squamous cell carcinoma.

Authors:  Wenwen Zheng; Kangqi Li; Weiwei Zhu; Yuexia Ding; Qingna Wu; Qiling Tang; Congxiao Lu; Quan Zhao; Shengqiang Yu; Chenyu Guo
Journal:  Cancer Med       Date:  2020-06-10       Impact factor: 4.452

9.  Nomograms to predict overall and cancer-specific survival in patients with penile cancer.

Authors:  Wenbo Xu; Feng Qi; Yi Liu; Lizhuan Zheng; Zhengjun Kang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

10.  Prognostic Values of Different Clinicopathological Factors and Predictive Models for Penile Carcinoma.

Authors:  Yanxiang Shao; Thongher Lia; Yaohui Wang; Kan Wu; Xu Hu; Yang Liu; Shuyang Feng; Shangqing Ren; Zhen Yang; Sanchao Xiong; Weixiao Yang; Qiang Wei; Hao Zeng; Xiang Li
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.